Clinical Trial Update: A Study to Assess the Use of Methylone in the Treatment of PTSD [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 study evaluating methylone for Post-Traumatic Stress Disorder. Results were posted on 2026-04-15.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Methylone (3,4-methylenedioxy-N-methylcathinone)

Snippet

Sponsor: Transcend Therapeutics | Conditions: Post Traumatic Stress Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-04-15